<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1159" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1159/" /><meta name="ncbi_pagename" content="Arginase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Arginase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Arginase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/08/28" /><meta name="citation_author" content="Derek Wong" /><meta name="citation_author" content="Stephen Cederbaum" /><meta name="citation_author" content="Eric A Crombez" /><meta name="citation_pmid" content="20301338" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1159/" /><meta name="citation_keywords" content="Hyperargininemia" /><meta name="citation_keywords" content="Hyperargininemia" /><meta name="citation_keywords" content="Arginase-1" /><meta name="citation_keywords" content="ARG1" /><meta name="citation_keywords" content="Arginase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Arginase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Derek Wong" /><meta name="DC.Contributor" content="Stephen Cederbaum" /><meta name="DC.Contributor" content="Eric A Crombez" /><meta name="DC.Date" content="2014/08/28" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1159/" /><meta name="description" content="Arginase deficiency in untreated individuals is characterized by episodic hyperammonemia of variable degree that is infrequently severe enough to be life threatening or to cause death. Most commonly, birth and early childhood are normal. Untreated individuals have slowing of linear growth at age one to three years, followed by development of spasticity, plateauing of cognitive development, and subsequent loss of developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability. Seizures are common and are usually controlled easily." /><meta name="og:title" content="Arginase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Arginase deficiency in untreated individuals is characterized by episodic hyperammonemia of variable degree that is infrequently severe enough to be life threatening or to cause death. Most commonly, birth and early childhood are normal. Untreated individuals have slowing of linear growth at age one to three years, followed by development of spasticity, plateauing of cognitive development, and subsequent loss of developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability. Seizures are common and are usually controlled easily." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1159/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/arg1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1159/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B44CFE04210710000000003F90186.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="pmc" class="last">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1159_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1159_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/apert/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/args-aciduria/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1159_"><span class="title" itemprop="name">Arginase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Hyperargininemia</div><p class="contrib-group"><span itemprop="author">Derek Wong</span>, MD, <span itemprop="author">Stephen Cederbaum</span>, MD, and <span itemprop="author">Eric A Crombez</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1159_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1159_ai__"><div class="contrib half_rhythm"><span itemprop="author">Derek Wong</span>, MD<div class="affiliation small">University of California Los Angeles Medical Center<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.alcu.tendem@gnowad" class="oemail">ude.alcu.tendem@gnowad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Stephen Cederbaum</span>, MD<div class="affiliation small">University of California Los Angeles Medical Center<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.alcu.tendem@muabredecs" class="oemail">ude.alcu.tendem@muabredecs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Eric A Crombez</span>, MD<div class="affiliation small">Shire HGT<br />Cambridge, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.erihs@zebmorce" class="oemail">moc.erihs@zebmorce</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 21, 2004</span>; Last Update: <span itemprop="dateModified">August 28, 2014</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="arg1.Summary" itemprop="description"><h2 id="_arg1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Arginase deficiency in untreated individuals is characterized by episodic hyperammonemia of variable degree that is infrequently severe enough to be life threatening or to cause death. Most commonly, birth and early childhood are normal. Untreated individuals have slowing of linear growth at age one to three years, followed by development of spasticity, plateauing of cognitive development, and subsequent loss of developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability. Seizures are common and are usually controlled easily.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Many if not most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants will be identified by the current full-panel expanded <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> testing done in many states and countries. Three- to fourfold elevation of plasma arginine concentration above the upper limit of normal is highly suggestive of the diagnosis. The diagnosis is confirmed by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>ARG1</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or failure to detect arginase enzyme activity (usually &#x0003c;1% of normal) in red blood cell extracts.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management should closely mirror that for urea cycle disorders, except that individuals with arginase deficiency are unlikely to have episodes of hyperammonemia; if present, such episodes are likely to respond to conservative management (e.g., intravenous fluid administration). Treatment should be by a team coordinated by a metabolic specialist. Treatment of an acutely ill (comatose and encephalopathic) individual requires rapid reduction of plasma ammonia concentration, use of pharmacologic agents (sodium benzoate and/or sodium phenylbutyrate/phenylacetate) to allow excretion of excess nitrogen through alternative pathways, introduction of calories supplied by carbohydrates and fat to reduce catabolism and the amount of excess nitrogen in the diet, and physiologic stabilization with intravenous fluids and cardiac pressors as necessary while avoiding overhydration and resulting cerebral edema.</p><p><i>Prevention of primary manifestations:</i> Maintenance of plasma arginine concentration as near normal as possible through restriction of dietary protein and use of oral nitrogen-scavenging drugs.</p><p><i>Surveillance:</i> Regular follow-up at intervals determined by age and degree of metabolic stability.</p><p><i>Agents/circumstances to avoid:</i> Valproic acid (exacerbates hyperammonemia).</p><p><i>Evaluation of relatives at risk:</i> Plasma quantitative amino acid analysis, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (if the family-specific pathogenic variants are known), or enzymatic testing in all sibs (especially younger ones) of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to allow early diagnosis and treatment of those found to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><i>Other:</i> Prompt treatment of acute intercurrent illnesses with special dietary intervention or hospitalization to minimize the effect of catabolism.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Arginase deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Heterozygotes (carriers) are asymptomatic. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>ARG1</i> pathogenic variants in the family are known.</p></div></div><div id="arg1.Diagnosis"><h2 id="_arg1_Diagnosis_">Diagnosis</h2><div id="arg1.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Arginase deficiency <b>should be suspected</b> in either of the following:</p><ul><li class="half_rhythm"><div>Newborns with elevation of arginine on the current full-panel expanded <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> testing done in many states and countries</div></li><li class="half_rhythm"><div>Individuals with progressive loss of developmental milestones and spasticity</div></li></ul></div><div id="arg1.Preliminary_Testing"><h3>Preliminary Testing</h3><p><b>Plasma quantitative amino acid analysis.</b> Elevation of plasma arginine concentration three- to fourfold above the upper limit of normal is highly suggestive of the diagnosis. Plasma arginine elevation is the primary means of ascertainment.</p><p>Note: Up to twofold elevations may be seen in infants who do not have arginase deficiency and who are otherwise normal.</p><p><b>Plasma ammonia concentration.</b> Elevation of plasma ammonia concentration may be intermittent. Acute hyperammonemia (plasma ammonia concentration &#x0003e;150 &#x000b5;mol/L) is uncommon.</p><p><b>Urinary orotic acid concentration.</b> Although urinary orotic acid concentration is often elevated, it is not a primary screen for the disorder.</p></div><div id="arg1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of arginase deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ARG1</i> (see <a class="figpopup" href="/books/NBK1159/table/arg1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figarg1Tmoleculargenetictestingusedin" rid-ob="figobarg1Tmoleculargenetictestingusedin">Table 1</a>) or reduced red blood cell arginase enzyme activity.</p><p>Note: Until recently, red blood cell arginase enzyme testing was the gold standard for diagnostic confirmation; however, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is now readily available and is an alternative to enzyme testing as the first-line confirmatory test. Enzyme assay remains the norm if two pathogenic variants are not found.</p><p><b>Molecular genetic testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm">One <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategy is <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>ARG1</i> followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if both <i>ARG1</i> pathogenic variants are not identified on sequence analysis.</div></li><li class="half_rhythm"><div class="half_rhythm">An alternative <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategy is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>ARG1</i> and other genes of interest (see <a href="#arg1.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="arg1.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Arginase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1159/table/arg1.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arg1.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARG1</i></td><td headers="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td></tr><tr><td headers="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_arg1.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="arg1.TF.1.1"><p class="no_margin">See <a href="/books/NBK1159/#arg1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#arg1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="arg1.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="arg1.TF.1.3"><p class="no_margin">Sequence analysis of the <i>ARG1</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> has detected pathogenic variants in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals tested to date, but sample size is small and no statement about variant detection rate can be made at this time [J Haberle, personal communication].</p></div></dd><dt>4. </dt><dd><div id="arg1.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="arg1.TF.1.5"><p class="no_margin">Whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, beginning in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1 and including the remainder of the gene, has been reported [<a class="bk_pop" href="#arg1.REF.korman.2004.857">Korman et al 2004</a>]</p></div></dd></dl></div></div></div><p><b>Measurement of red blood cell arginase enzyme activity.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have no detectable arginase enzyme activity (usually &#x0003c;1% of normal) in red blood cell extracts.</p><p>Note: (1) Although arginase is stable, a control sample should be obtained and treated identically if the cells are to be shipped to a distant site. (2) Arginase enzyme activity is reduced in liver as well as red blood cells, but arginase enzyme activity in liver is rarely measured because of the risks involved in liver biopsy and the ease of diagnosis from red blood cells.</p></div></div><div id="arg1.Clinical_Characteristics"><h2 id="_arg1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="arg1.Clinical_Description"><h3>Clinical Description</h3><p>Unlike any of the other eight primary urea cycle disorders (see <a href="/books/n/gene/ucd-overview/">Urea Cycle Disorders Overview</a>), arginase deficiency rarely results in elevated plasma ammonia concentration in the newborn period, even in individuals with two <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants. Episodic hyperammonemia of variable degree may occur but is rarely severe enough to be life threatening or to cause death. Hyperammonemia is often recognized only if blood ammonia or plasma amino acid concentrations are obtained during an acute illness. Although data are not available, it appears that more than 75% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals survive their disease and live long, albeit handicapped lives.</p><p>Most commonly, birth and early childhood are normal. At the age of one to three years, linear growth slows and spasticity, more commonly spastic diplegia, begins to develop. Soon, previously normal cognitive development slows or stops and the child begins to lose developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability.</p><p>Some children are more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> cognitively, whereas others have more severe spasticity and secondary joint contractures.</p><p>All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have growth deficiency.</p><p>Seizures are common and are usually controlled easily.</p><p>Microcephaly is common and brain imaging often reveals cortical atrophy.</p><p>Other parts of the nervous system including basal ganglia, cerebellum, medulla, and spinal cord are largely spared [<a class="bk_pop" href="#arg1.REF.de_deyn.1997">De Deyn et al 1997</a>].</p><p>Older individuals may present with postoperative encephalopathy.</p></div><div id="arg1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been described.</p><p>The degree of enzyme deficiency in red blood cells or the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> cannot be used to establish disease severity or prognosis as they are but two of several factors involved in the outcome.</p></div><div id="arg1.Prevalence"><h3>Prevalence</h3><p>Arginase deficiency is thought to be one of the least common of the urea cycle defects. Its incidence has been estimated at between 1:350,000 and 1:1,000,000; the true incidence in non-related populations is unknown.</p><p>Arginase deficiency may be more common in parts of Japan and among French Canadians.</p></div></div><div id="arg1.Genetically_Related_Allelic_Disorde"><h2 id="_arg1_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>ARG1</i>.</p></div><div id="arg1.Differential_Diagnosis"><h2 id="_arg1_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Hyperammonemia.</b> Arginase is the sixth and final enzyme of the eight known steps in the urea cycle. See <a href="/books/n/gene/ucd-overview/">Urea Cycle Disorders Overview</a> for approaches to distinguish:</p><ul><li class="half_rhythm"><div>Other causes of hyperammonemia from a urea cycle disorder; and</div></li><li class="half_rhythm"><div>The differences between the urea cycle disorders themselves.</div></li></ul><p><b>Spasticity.</b> Arginase deficiency may be misdiagnosed as static spastic diplegia (cerebral palsy). It should be noted that arginase deficiency is one of the few treatable causes of spastic diplegia [<a class="bk_pop" href="#arg1.REF.prasad.1997.301">Prasad et al 1997</a>].</p><p><b><i>ARG2</i>.</b> A second arginase <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is known (<i>ARG2</i>), but no human deficiency state has been identified and it is not clear that elevated plasma arginine would be a part of such a deficiency.</p></div><div id="arg1.Management"><h2 id="_arg1_Management_">Management</h2><div id="arg1.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with arginase deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Plasma ammonia concentration</div></li><li class="half_rhythm"><div>Plasma arginine concentration</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Complete neurologic evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="arg1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The management of individuals with arginase deficiency should closely mirror that described in the <a href="/books/n/gene/ucd-overview/">Urea Cycle Disorders Overview</a>, with one caveat: individuals with arginase deficiency are less prone to episodes of hyperammonemia and when present, hyperammonemia is more likely to respond to conservative management such as intravenous fluid administration. However, the individual who is comatose and encephalopathic is at high risk for severe brain damage and should be treated accordingly. Arginine supplementation is obviously contraindicated.</p><p><b>Infants</b> should be managed by a team coordinated by a metabolic specialist in a specialized center. In the acute phase, the mainstays of treatment are the following:</p><ul><li class="half_rhythm"><div><b>Rapidly reducing plasma ammonia concentration.</b> The best way to reduce plasma ammonia concentration quickly is by dialysis; the faster the flow rate of dialysate, the faster the clearance of ammonia from the plasma. The method employed depends on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's circumstances and available resources. Fastest is use of pump-driven dialysis, in which an extracorporeal membrane oxygenation (ECMO) pump is used to drive a hemodialysis (HD) machine. Other methods are "routine" hemodialysis, hemofiltration (both arteriovenous and venovenous), peritoneal dialysis, and continuous-drainage peritoneal dialysis. Dialysis can usually be discontinued when plasma ammonia concentration falls below 200 &#x000b5;mol/L. Affected individuals often experience a "rebound" hyperammonemia that may require further dialysis, although rarely is this level of intervention required in arginase deficiency.</div></li><li class="half_rhythm"><div><b>Pharmacologic management to allow alternative pathway excretion of excess nitrogen.</b> Blocking of ammonia production and the need for ureagenesis is accomplished by diminishing catabolism with adequate non-protein calories and with a combination of the nitrogen scavenger drugs sodium phenylacetate and sodium benzoate. A loading dose of the drugs is followed by maintenance administration, initially intravenously and later orally when the individual is stable. Intravenous forms of these medications are now approved by the FDA and are generally available.</div></li><li class="half_rhythm"><div><b>Reducing the amount of excess nitrogen in the diet and reducing catabolism through the introduction of calories supplied by carbohydrates and fat.</b> In acutely ill individuals, calories should be provided as carbohydrate and fat, either intravenously as glucose and Intralipid<sup>&#x000ae;</sup> or orally as protein-free oral formula, such as Mead Johnson 80056<sup>&#x000ae;</sup> or Ross Formula ProPhree<sup>&#x000ae;</sup>; however, complete restriction of protein should not exceed 24-48 hours, as depletion of essential amino acids may result in endogenous protein catabolism and nitrogen release. High parenteral glucose plus insulin can be used acutely to diminish endogenous protein catabolism. Individuals should be transitioned from parenteral to enteral feeds as soon as possible. In early treatment, feeding 1.0 to 1.5 g of protein/kg body weight with 50% as essential amino acids is advised, particularly for infants. Older children require and tolerate lower protein intake.</div></li><li class="half_rhythm"><div><b>Reducing the risk of neurologic damage.</b> Cautionary measures are physiologic stabilization with intravenous fluids (10% dextrose with one-quarter normal saline) and cardiac pressors as necessary while avoiding overhydration and resulting cerebral edema, the duration of which correlates with poor neurologic outcome.</div></li></ul><p><b>Older individuals</b> are at risk for episodes of hyperammonemia and should continue to be managed by a specialist in metabolic disorders.</p><p><b>Seizures</b> are easily treated by phenobarbital or carbamazepine.</p><p><b>Acute intercurrent illnesses</b> should be treated promptly with special dietary intervention or hospitalization to minimize the effect of catabolism.</p></div><div id="arg1.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>The goal should be maintenance of plasma arginine concentration as near normal as possible, consistent with the individual's tolerance for the following interventions:</p><ul><li class="half_rhythm"><div><b>Restriction of dietary protein through use of specialized formulas.</b> In the best of circumstances, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual should be on the minimal protein intake needed to maintain protein biosynthetic function, growth, and normal or near-normal plasma amino acid concentrations. Half or more of dietary protein should be an arginine-free essential amino acid mixture.</div></li><li class="half_rhythm"><div><b>Administration of oral nitrogen scavenging drugs.</b> Sodium phenylbutyrate/glycerolphenylbutyrate at a dose of 350-600 mg/kg/day in patients weighing less than 20 kg, or 9.9-13.0 g/m<sup>2</sup>/day in larger patients. The medicines are to be taken in equally divided amounts with each meal or feeding (i.e., 3-6x/day) [<a class="bk_pop" href="#arg1.REF.de_deyn.1997">De Deyn et al 1997</a>, <a class="bk_pop" href="#arg1.REF.iyer.1998.86">Iyer et al 1998</a>, <a href="http://www.rarediseasesnetwork.org/ucdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Urea Cycle Disorders Consortium</a>].</div></li><li class="half_rhythm"><div>Liver transplantation eliminates the hyperargininemia and presumably the risk for hyperammonemia.</div></li></ul></div><div id="arg1.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Most individuals with arginase deficiency have persistent hepatic synthetic function abnormalities; particularly, elevated prothrombin time.</p><p>In some circumstances hepatic fibrosis and cirrhosis have developed and have either been fatal or required a liver transplant.</p><p>Arginine is the substrate for nitric oxide synthase; however, abnormalities in this pathway have not been described.</p><p>The spasticity may be reactive and instances of marked improvement with Botox<sup>&#x000ae;</sup> have been described.</p></div><div id="arg1.Surveillance"><h3>Surveillance</h3><p>Patients are seen at regular intervals determined by their age and degree of metabolic stability.</p><p>Infants should be seen monthly or more frequently, with monitoring of plasma concentration of ammonia and amino acids, growth, and neurologic function. If treatment fails to arrest the neurologic deterioration or if spasticity is symptomatic, appropriate orthopedic and physical therapy interventions are indicated.</p></div><div id="arg1.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Valproic acid is to be avoided as it exacerbates hyperammonemia in urea cycle defects and other inborn errors of metabolism [<a class="bk_pop" href="#arg1.REF.scaglia.2006.113">Scaglia &#x00026; Lee 2006</a>].</p></div><div id="arg1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Because the age of onset of arginase deficiency is delayed beyond the newborn period and the manifestations can vary, the genetic status of all sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (especially the younger ones) should be clarified so that morbidity can be reduced by early diagnosis and treatment in those who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Testing methods can include any one of the following:</p><ul><li class="half_rhythm"><div>Plasma quantitative amino acid analysis</div></li><li class="half_rhythm"><div>Molecular genetic testing (if the family-specific <i>ARG1</i> pathogenic variants are known)</div></li><li class="half_rhythm"><div>Analysis of enzymatic activity in red blood cells</div></li></ul><p>See <a href="#arg1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="arg1.Pregnancy_Management"><h3>Pregnancy Management</h3><p>The authors are not aware of any instance in which pregnancy has been reported in a woman with arginase deficiency; therefore, no inference can be drawn about the safety of pregnancy for the mother or the fetus.</p></div><div id="arg1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="arg1.Other"><h3>Other</h3><p>Immunizations can be provided on the usual schedule.</p><p>Multivitamin and fluoride supplementation are indicated for all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Appropriate use of antipyretics is indicated. Ibuprofen is preferred over acetaminophen.</p></div></div><div id="arg1.Genetic_Counseling"><h2 id="_arg1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="arg1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Arginase deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="arg1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore carry one <i>ARG1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ARG1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Although most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have not reproduced, those who are successfully treated are likely to be fertile.</div></li><li class="half_rhythm"><div>The offspring of an individual with arginase deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ARG1</i>.</div></li><li class="half_rhythm"><div>The rarity of the condition makes it unlikely that an unrelated reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> whose ancestors do not come from a confined geographic area will be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ARG1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="arg1.Carrier_Detection"><h3>Carrier Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>ARG1</i> pathogenic variants in the family.</p><p><b>Biochemical genetic testing.</b> The normal mean red blood cell arginase enzyme activity is 100 times the lower limit of detection. Thus, most obligate carriers have been easily distinguished from normal. However, in at least one instance, a mother who was an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a> tested in the mid-normal range.</p></div><div id="arg1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#arg1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are under treatment for arginase deficiency, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="arg1.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> If both <i>ARG1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Biochemical genetic testing.</b> If <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is not possible, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at 25% risk may be possible by measuring arginase enzyme activity in fetal red blood cells obtained by percutaneous umbilical blood sampling after 18 weeks' gestation [<a class="bk_pop" href="#arg1.REF.hewson.2003.607">Hewson et al 2003</a>, <a class="bk_pop" href="#arg1.REF.korman.2004.857">Korman et al 2004</a>].</p><p>Neither amniocytes nor chorionic villous cells normally have arginase enzyme activity and thus are unsuitable for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> using biochemical testing.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="arg1.Resources"><h2 id="_arg1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=arginasedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Arginase deficiency</a></div></li><li class="half_rhythm"><div><b>National Urea Cycle Disorders Foundation</b></div><div>75 South Grand Avenue</div><div>Pasadena CA 91105</div><div><b>Phone:</b> 800-386-8233 (toll-free); 626-578-0833</div><div><b>Fax:</b> 626-578-0823</div><div><b>Email:</b> info@nucdf.org</div><div><a href="http://www.nucdf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nucdf.org</a></div></li><li class="half_rhythm"><div><b>Medical Home Portal</b></div><div><i>The Parents &#x00026; Families section of the Medical Home Portal provides information and resources to help families learn how to better care for a child with chronic and complex conditions and to become more effective partners in their child&#x02019;s care.</i></div><div>Department of Pediatrics University of Utah</div><div>P.O. Box 581289</div><div>Salt Lake City UT 84158</div><div><b>Phone:</b> 801-213-3920</div><div><b>Email:</b> info@medicalhomeportal.org</div><div><a href="https://www.medicalhomeportal.org/living-with-child" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">For Parents &#x00026; Families</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>European Registry and Network for Intoxication Type Metabolic Diseases (E-IMD)</b></div><div><a href="https://www.e-imd.org/event/european-registry-and-network-intoxication-type-metabolic-diseases" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.e-imd.org/en/index.phtml</a></div></li><li class="half_rhythm"><div><b>Urea Cycle Disorder International Patient Registry</b></div><div><b>Phone:</b> 626-578-0833</div><div><b>Fax:</b> 626-578-0823</div><div><b>Email:</b> coordinator@ucdparegistry.org</div><div><a href="https://ucdparegistry.patientcrossroads.org/index.php?option=com_content&#x00026;view=article&#x00026;id=412&#x00026;Itemid=484" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ucdregistry.org</a></div></li><li class="half_rhythm"><div><b>Urea Cycle Disorders Consortium Registry</b></div><div>Children's National Medical Center</div><div><b>Phone:</b> 202-306-6489</div><div><b>Email:</b> jseminar@childrensnational.org</div><div><a href="https://www.rarediseasesnetwork.org/cms/ucdc/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarediseasesnetwork.org/cms/ucdc/</a></div></li></ul></div><div id="arg1.Molecular_Genetics"><h2 id="_arg1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="arg1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Arginase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1159/table/arg1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arg1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_arg1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_arg1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_arg1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_arg1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_arg1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_arg1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_arg1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/383" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ARG1</i></a></td><td headers="hd_b_arg1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=383" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_arg1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P05089" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Arginase-1</a></td><td headers="hd_b_arg1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/ARG1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ARG1 @ LOVD</a></td><td headers="hd_b_arg1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ARG1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ARG1</a></td><td headers="hd_b_arg1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ARG1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ARG1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="arg1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="arg1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Arginase Deficiency (<a href="/omim/207800,608313" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1159/table/arg1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arg1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/207800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">207800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ARGININEMIA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608313" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608313</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ARGINASE 1; ARG1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ARG1</i> is approximately 10-15 kb in length and comprises eight exons and seven introns (see <a href="http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000118520" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ensembl Gene Report</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1159/#arg1.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants are located throughout the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Missense variants are generally found in amino acids that have been highly conserved during evolution and especially in sequences involved in the active site of the enzyme. Chain-terminating variants and deletions and insertions may be found anywhere in the gene [<a class="bk_pop" href="#arg1.REF.vockley.1996.44">Vockley et al 1996</a>]. A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of nearly the entire gene has also been described [<a class="bk_pop" href="#arg1.REF.korman.2004.857">Korman et al 2004</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Arginase-1 is 322 amino acids long and is manganese dependent; it exists in nature as a trimer, and, unlike arginase-2, which is located in mitochondrial matrix, is located in the cytosol. The enzyme is highly stable and can be completely reactivated, if not denatured, by treating with manganese at 65&#x000b0; C. Expression is highest in the liver and RBCs (Reference sequence <a href="/entrez/viewer.fcgi?val=NP_000036.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000036.2</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mutated arginase-1 protein is rarely stable enough to be detected in the mature red blood cells of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals by immunologic means.</p><p>A second, ancestral arginase <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (<i>ARG2</i>) located on 14q, is expressed in different tissue and cell types and may partially compensate for deficiency of arginase-1. It is thought that from an evolutionary perspective, <i>ARG2</i> existed first and that <i>ARG1</i> arose from it following a gene <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> event. The two gene products are more than 50% homologous at the amino acid level [<a class="bk_pop" href="#arg1.REF.morris.1997.157">Morris et al 1997</a>, <a class="bk_pop" href="#arg1.REF.iyer.1998.86">Iyer et al 1998</a>].</p></div><div id="arg1.References"><h2 id="_arg1_References_">References</h2><div id="arg1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.de_deyn.1997">De Deyn PP, Marescau B, Qureshi IE, Cederbaum SD, Lambert M, Cerone R, Chamoles N, Specola N, Leonard JV, Gatti R, Kang SS, Mizutani N, Rezvani I, Snyderman SE, Terheggen HG, Yoshino M, Appel B, Martin JJ, Beaudet AL, Vilarinho L, Hirsch E, Jakobs K, van der Knaap MS, Naito H, Pickut BA, Shapira SK, Fuchshuber A, Roth B, Hylan K. Hyperargininemia: a treatable inborn error of metabolism? In: De Deyn PP, Marescau B, Qureshi IA, Mori A, eds. <em>Guanidino Compounds in Biology and Medicine II.</em> London, UK: John Libbey; 1997:53-69.</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.hewson.2003.607">Hewson S, Clarke JT, Cederbaum S. Prenatal diagnosis for arginase deficiency: a case study. <span><span class="ref-journal">J Inherit Metab Dis. </span>2003;<span class="ref-vol">26</span>:607–10.</span> [<a href="/pubmed/14605507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14605507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.iyer.1998.86">Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW, Cederbaum S. The human arginases and arginase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1998;<span class="ref-vol">21</span> Suppl 1:86–100.</span> [<a href="/pubmed/9686347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9686347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.korman.2004.857">Korman SH, Gutman A, Stemmer E, Kay BS, Ben-Neriah Z, Zeigler M. Prenatal diagnosis for arginase deficiency by second-trimester fetal erythrocyte arginase assay and first-trimester ARG1 mutation analysis. <span><span class="ref-journal">Prenat Diagn. </span>2004;<span class="ref-vol">24</span>:857–60.</span> [<a href="/pubmed/15565656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15565656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.morris.1997.157">Morris SM Jr, Bhamidipati D, Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. <span><span class="ref-journal">Gene. </span>1997;<span class="ref-vol">193</span>:157–61.</span> [<a href="/pubmed/9256072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9256072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.prasad.1997.301">Prasad AN, Breen JC, Ampola MG, Rosman NP. Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review. <span><span class="ref-journal">J Child Neurol. </span>1997;<span class="ref-vol">12</span>:301–9.</span> [<a href="/pubmed/9378897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9378897</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.scaglia.2006.113">Scaglia F, Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2006;<span class="ref-vol">142C</span>:113–20.</span> [<a href="/pmc/articles/PMC4052756/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4052756</span></a>] [<a href="/pubmed/16602094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16602094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.vockley.1996.44">Vockley JG, Goodman BK, Tabor DE, Kern RM, Jenkinson CP, Grody WW, Cederbaum SD. Loss of function mutations in conserved regions of the human arginase I gene. <span><span class="ref-journal">Biochem Mol Med. </span>1996;<span class="ref-vol">59</span>:44–51.</span> [<a href="/pubmed/8902193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8902193</span></a>]</div></li></ul></div><div id="arg1.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.boles.2006.390">Boles RG, Stone ML. A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">89</span>:390–1.</span> [<a href="/pubmed/16963300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16963300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arg1.REF.crombez.2005.243">Crombez EA, Cederbaum SD. Hyperargininemia due to liver arginase deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">84</span>:243–51.</span> [<a href="/pubmed/15694174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15694174</span></a>]</div></li></ul></div></div><div id="arg1.Chapter_Notes"><h2 id="_arg1_Chapter_Notes_">Chapter Notes</h2><div id="arg1.Author_Notes"><h3>Author Notes</h3><p>Stephen Cederbaum is Professor Emeritus of Psychiatry, Pediatrics, and Human Genetics at UCLA. His area of special interest is biochemical genetics.</p><p>Eric Crombez is a specialist in biochemical genetics. He was formerly co-director, with Dr Cederbaum, of the Urea Cycle Disorders Consortium site at UCLA and is now at Shire HGT in Cambridge, MA.</p><p>Derek Wong is Associate Clinical Professor of Pediatrics at UCLA. He is the Director of the Urea Cycle Disorders Consortium site at UCLA, and is the Head of Biochemical Genetics.</p></div><div id="arg1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>28 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 February 2012(me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 October 2010 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>1 September 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 June 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and prenatal testing available for <i>ARG1</i> mutations</div></li><li class="half_rhythm"><div>13 February 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 October 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>2 March 2004 (sc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1159</span><span class="label">PMID: <a href="/pubmed/20301338" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301338</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/apert/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/args-aciduria/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1159&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1159/?report=reader">PubReader</a></li><li><a href="/books/NBK1159/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1159" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1159" style="display:none" title="Cite this Page"><div class="bk_tt">Wong D, Cederbaum S, Crombez EA. Arginase Deficiency. 2004 Oct 21 [Updated 2014 Aug 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1159/pdf/Bookshelf_NBK1159.pdf">PDF version of this page</a> (172K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#arg1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#arg1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#arg1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#arg1.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#arg1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#arg1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#arg1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#arg1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#arg1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#arg1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#arg1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=383[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ARG1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content" style="display: none;"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1497202" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1497202" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1497202" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1497202" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301631" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22649802" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Camacho J, Rioseco-Camacho N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21290785" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Argininosuccinate Lyase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Argininosuccinate Lyase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nagamani SCS, Erez A, Lee B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301338" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301338" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0429e739a66ee2baa5f641">Arginase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Arginase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:32:55-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B44CFE04210710000000003F90186&amp;ncbi_session=CE8B44CFE0429E61_1017SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1159%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1159&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1159/&amp;ncbi_pagename=Arginase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B44CFE0429E61_1017SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>